论文部分内容阅读
对88例妊高征孕妇应用胎心监护仪和B超监测胎儿生物物理活动(BPS),彩色多普勒测定脐血流速波收缩期振幅与舒张期振幅比值(S/D),和脐动脉血(UmA)pH监测胎儿预后。结果显示:应用安定和硫酸镁治疗后BPS反应良好的病例(双反应组),和用药前BPS反应良好,用药后反应不良的病例(单反应组),妊高征发病和持续时间及新生儿体重均明显不同于用药前后EPS无反应的病例(无反应组)。而单反应组和无反应组治疗所用药物剂量明显高于双反应组(P<0.001),三组间s/D比值,pH和胎儿预后,除了S/D≥3和pH在7.21～7.24项外,均育明显区别(P<0.005)。提示BPS和S/D比值联台监护妊高征胎儿预后是一种安全、可靠的产前监测方法。
Eighty - eight pregnant women with PIH were enrolled in this study. Fetal cardiograph and B - ultrasound were used to monitor fetal biological activity (BPS). Color Doppler was used to measure the systolic and diastolic amplitude ratio (S / D) Arterial blood (UmA) pH monitoring of fetal prognosis. The results showed that patients with good BPS response after treatment with diazepam and magnesium sulfate (double reaction group) had good response to pre-medication BPS, poor response after medication (single-response group), incidence and duration of PIH and neonatal Body weight were significantly different from before and after treatment with no response to EPS cases (no response group). However, the doses of drugs used in the treatment group were significantly higher than those in the two response groups (P <0.001). The s / D ratio, pH and fetal prognosis among the three groups except S / D≥3 and pH ranged from 7.21 to 7.24 The difference was significant (P <0.005). Prompt BPS and S / D ratio combined with monitoring pregnancy-induced hypertension fetus fetus prognosis is a safe and reliable method of prenatal monitoring.